Politics
The FDA must stop dragging its feet and withdraw mifepristone for abortion
CRAYON summary
A piece published in The Hill argues that the FDA should withdraw mifepristone for use in abortion and contends that the agency has delayed acting. The piece says delay has consequences and argues that women, including one it identifies as Herring, and their unborn children should be protected now rather than face further bureaucratic delays.
Based on The Hill's report - only one outlet has covered this so far. Read the original.▲ Sign in to vote stories up
Coverage 1 source · 1 report
Chronological.
-
The FDA must stop dragging its feet and withdraw mifepristone for abortion
Every day of delay has consequences. Women like Herring and their unborn children deserve protection now — not more bureaucratic excuses and endless delays.
Discussion 0 comments